Midatech Pharma plc (LON:MTPH – Get Rating)'s stock price crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 10.66 ($0.13) and traded as low as GBX 8.49 ($0.10). Midatech Pharma shares last traded at GBX 9 ($0.11), with a volume of 352,596 shares.
Midatech Pharma Stock Performance
The firm has a market capitalization of £8.86 million and a price-to-earnings ratio of -1.32. The company has a fifty day moving average of GBX 10.66 and a two-hundred day moving average of GBX 10.99. The company has a debt-to-equity ratio of 9.52, a quick ratio of 5.28 and a current ratio of 5.28.
About Midatech Pharma
(Get Rating)
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection.
See Also
- The Institutions Hold On To Darden Restaurants International
- What Steelcase's Earnings Say About the Return to the Office?
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Midatech Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Midatech Pharma and related companies with MarketBeat.com's FREE daily email newsletter.